WallStreetZenWallStreetZen

NASDAQ: ANAB
Anaptysbio Inc Stock Ownership - Who owns Anaptysbio?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Anaptysbio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric J. LoumeauCHIEF LEGAL OFFICER2025-09-305,000$14.02
$70.10kBuy
Eric J. LoumeauCHIEF LEGAL OFFICER2025-09-308,240$29.00
$238.96kSell
Hollings RentonDirector2025-08-087,121$19.70
$140.26kSell
Hollings RentonDirector2025-08-083,110$19.44
$60.46kSell
Hollings RentonDirector2025-08-0810,231$6.93
$70.90kBuy
Hollings RentonDirector2025-07-0220,925$6.93
$145.01kBuy
Hollings RentonDirector2025-07-027,250$23.09
$167.41kSell
Hollings RentonDirector2025-07-0213,675$23.82
$325.78kSell
Dennis M. FentonDirector2025-06-183,015$23.97
$72.27kSell
Hollings RentonDirector2025-06-183,015$23.97
$72.27kSell

1 of 3

ANAB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANAB insiders and whales buy or sell their stock.

ANAB Shareholders

What type of owners hold Anaptysbio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC96.47%27,008,838$976.64MInsider
Ecor1 Capital LLC28.15%7,880,094$284.94MInstitution
Oleg Nodelman25.54%7,151,624$258.60MInsider
First Light Asset Management LLC12.64%3,539,593$127.99MInstitution
Point72 Asset Management LP8.84%2,474,874$89.49MInstitution
Avalon Ventures VII L P7.28%2,036,932$73.66MInsider
Holdings A. Novo6.92%1,936,604$70.03MInsider
Morgan Stanley6.68%1,869,840$67.61MInstitution
Blackrock Inc6.38%1,786,934$64.62MInstitution
Vanguard Group Inc5.49%1,537,550$55.60MInstitution

1 of 3

ANAB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANAB46.37%53.63%Net BuyingNet Selling
KOD67.70%32.30%Net Selling
RAPP70.43%29.57%Net SellingNet Selling
ORKA18.31%81.69%Net BuyingNet Buying
MNMD48.27%51.73%Net SellingNet Selling
View Top Biotech Stocks

Anaptysbio Stock Ownership FAQ

Who owns Anaptysbio?

Anaptysbio (NASDAQ: ANAB) is owned by 131.36% institutional shareholders, 151.94% Anaptysbio insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Anaptysbio shareholder, owning 27.01M shares representing 96.47% of the company. Ecor1 Capital LLC's Anaptysbio shares are currently valued at $975.56M.

If you're new to stock investing, here's how to buy Anaptysbio stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.